WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005049015) USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/049015    International Application No.:    PCT/HR2004/000053
Publication Date: 02.06.2005 International Filing Date: 19.11.2004
IPC:
A61K 31/416 (2006.01), A61K 31/4162 (2006.01), A61K 31/55 (2006.01), A61K 31/695 (2006.01)
Applicants: PLIVA - ISTRAZIVACKI INSTITUT D.O.O. [HR/HR]; Prilaz baruna Filipovica 29, 10000 Zagreb (HR) (For All Designated States Except US).
MERCEP, Mladen [HR/HR]; (HR) (For US Only).
MESIC, Milan [HR/HR]; (HR) (For US Only).
PESIC, Dijana [HR/HR]; (HR) (For US Only)
Inventors: MERCEP, Mladen; (HR).
MESIC, Milan; (HR).
PESIC, Dijana; (HR)
Common
Representative:
PLIVA - ISTRAZIVACKI INSTITUT D.O.O.; Pravni I Patentni Poslovi, Prilaz Baruna Filipovica 29, 10000 Zagreb (HR)
Priority Data:
P20030956A 21.11.2003 HR
Title (EN) USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
(FR) UTILISATION DE 1,2-DIAZA-DIBENZO[E,H]AZULENES POUR LA FABRICATION DE PREPARATIONS PHARMACEUTIQUES DESTINEES A TRAITER ET PREVENIR DES MALADIES ET DES TROUBLES DU SYSTEME NERVEUX CENTRAL
Abstract: front page image
(EN)The present invention relates to the use of compounds from the group of 1,2-diaza­dibenzo[e,h]azulenes and of their pharmacologically acceptable salts and solvates for the manufacture of a pharmaceutical formulation for the treatment and prevention of diseases, damages and disorders of the central nervous system (CNS) caused by disorders of the neurochemical equilibrium of biogenic amines or other neurotransmitters.
(FR)La présente invention concerne l'utilisation de composés provenant du groupe des 1,2-diaza-dibenzo[e,h]azulènes et de leurs sels et solvates pharmaceutiquement acceptables pour la fabrication d'une préparation pharmaceutique destinée à traiter et prévenir des maladies, des lésions et des troubles du système nerveux central (SNC) causés par des troubles de l'équilibre neurochimique des amines biogéniques ou d'autres neurotransmetteurs.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)